Events
As active members of the translational imaging community, Invicro scientists attend, exhibit, and deliver talks at a variety of industry events. For more information on how to connect with our team at events or to inquire about setting up a meeting, please contact us.
SITC | November 6 – 11, 2019 | National Harbor, MD
https://www.sitcancer.org/2019/home
National Harbor, MD
11/6- 11/10
Booth # 342
The Society for Immunotherapy of Cancer (SITC) will welcome delegates to the 34th Annual Meeting & Pre-Conference Programs (SITC 2019) on Nov. 6–10, 2019 at the Gaylord National Hotel & Convention Center in National Harbor, Md.
SABCS | December 10 – 14, 2019 | San Antonio, TX
https://www.sabcs.org/2019-SABCS
San Antonio, TX
12/10- 12/14
Booth # 830
SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
IO 360 | February 26-28, 2020 | New York, NY
BIO IT World | April 21-23, 2020 | Boston, MA
https://www.bio-itworldexpo.com/
Booth #: 525
In the spirit of open collaboration, the world’s premier bio-IT conference will bring together the community to focus on how we are using technologies and analytic approaches to solve problems, accelerate science, and drive the future of precision medicine. With a focus on AI, data science and other “data-driven” technologies that are advancing biomedical research, drug discovery and healthcare, the Bio-IT World Conference & Expo ’20 will bring together more than 3,000 participants to the Seaport World Trade Center in Boston from April 21-23.
AACR | April 24-29, 2020 | San Diego, CA
https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=213&DetailItemID=1057
Booth #2241
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.
ASCO | May 29- June 2, 2020 | Chicago, IL
https://meetings.asco.org/am/program
Booth #: TBD
ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide.
SNMMI | June 13-16, 2020 | New Orleans, LA
Booth #: 359
The SNMMI 2020 Annual Meeting is recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. The four day event, taking place each June, provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.
DIA | June 14-18, 2020 | Washington D.C.
https://www.diaglobal.org/en/flagship/dia-2020/about/conference
Booth #: 1850
Fueled by the ideas of more than 7000 attendees, the DIA 2020 Global Annual Meeting will bring together patients, industry, regulators, and academia from all angles of the product lifecycle, from more than 50 countries. It’s the intersection of science, healthcare, and regulation, with no barriers, just a catalyst for thoughtful dialogue and debate.
Read more at https://www.diaglobal.org/en/flagship/dia-2020/about/conference#LiM8clVymWxZs5Bd.99
2020 Imaging Symposium | Stay Tuned | Boston, MA
Software Meeting | September 23, 2020 | Boston, MA
Come participate in interactive discussions and thought-provoking presentations from Invicro’s software users, senior development team, and application engineers on new and exciting imaging informatics workflows. We will walk users through the latest advances in VivoQuant® and iPACS®.
HAI | January 15-17, 2020 | Miami, FL
At HAI 2020 we will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend? Our discussions primarily spring from brief presentations by active investigators who will report on unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer’s-related disease.